Rhinosporidiosis is a chronic granulomatous disease caused by Rhinosporidium seeberi. It usually affects mucous membranes of the nose, nasopharynx, and ocular conjunctiva. Cutaneous, laryngeal, tracheal, genital, and bony dissemination is rare. Laryngotracheal involvement poses many diagnostic and therapeutic challenges. A 45-year-old South Indian man presented with complaints of a mass in both nostrils for 2 years, associated with progressive hoarseness of voice and difficulty in breathing for 6 months. Rhinosporidial lesions were seen bilaterally in the nasal cavity. Telescopic and fiberoptic laryngoscopic examinations showed reddish, strawberry-like masses with whitish spots on their surface involving the larynx and trachea. Computed tomography of the head and neck revealed soft-tissue mass lesions involving the bilateral nasal cavities and nasopharynx, extending to the oropharynx and involving the larynx and trachea. A preliminary tracheostomy was performed, followed by direct laryngoscopic excision of the laryngeal lesions and rigid-bronchoscopy-guided excision of the tracheal lesions. The patient was prescribed dapsone and advised to take it for 2 years. At 2 years of follow-up, there was no recurrence.
Introduction
Rhinosporidiosis is a chronic, granulomatous infection caused by the hydrophilic agent Rhinosporidium seeberi, and it is characterized by the chronic and benign evolution of reddish polypoidal masses primarily affecting the mucous membranes of the nose, nasopharynx, and conjunctiva. The condition is most common in southern India and Sri Lanka. 1 Cutaneous, laryngeal, tracheal, genitalia, and bony dissemination is rare, and lesions at these sites may mimic soft-tissue sarcoma. [1] [2] [3] Several decades usually elapse between the onset of nasal lesions and systemic dissemination. 1 We report an unusual case of nasal rhinosporidiosis involving the larynx and trachea.
Case report
A 45-year-old South Indian man, an agricultural laborer, presented with complaints of a mass in both nostrils for 2 years, associated with progressive hoarseness of his voice and difficulty in breathing for 6 months. He had experienced multiple episodes of bleeding from the nasal mass. About 6 months earlier, the patient had started noticing the voice change, which was progressive and associated with a cough with blood-stained sputum. He also gave a history of chronic irritation in his throat. He had no history of surgery for the lesions. The patient used to bathe in a pond, but no one else in his locality suffered from a similar illness. He had not traveled to a foreign country.
On nasal examination, reddish, nodular, hemorrhagic, irregularly surfaced lesions studded with whitish specs were seen on the mucosa of both nares, including the vestibule extending to the nasopharynx and hanging into the oropharynx (figure 1). Telescopic laryngoscopic examination showed a reddish, strawberry-like mass with whitish spots on its surface in the larynx, involving the glottis and subglottis. Fiberoptic laryngoscopic examination revealed a large, pedunculated, reddish, strawberry-like mass (figure 2) occluding the tracheal lumen, along with multiple sessile lesions.
Computed tomography (CT) of the head and neck revealed soft-tissue lesions involving the bilateral nasal cavities and nasopharynx, extending to the oropharynx and involving the larynx and trachea (figures 3 and 4). Findings of a complete hemogram, urinalysis, blood urea and sugar tests, chest radiography, fundoscopy and ultrasonography of the abdomen were normal. Human immunovirus and hepatitis B surface antigen serology was negative.
A clinical diagnosis of laryngotracheal rhinosporidiosis was made. Radiofrequency-assisted excision of the laryngeal lesions was performed under direct laryngoscopy, and excision of the tracheal lesions was performed with rigid bronchoscopic guidance following a preliminary tracheostomy. Histopathologic examination of the excised specimen (figure 5) revealed hyperplastic epithelium with various globular cysts of differing shapes, indicating sporangia at various stages of development. The patient was discharged after 7 days and advised to take dapsone 100 mg/day for 2 years. No recurrence was found at the 2-year follow-up.
Discussion
Rhinosporidiosis was first described by O'Kinealy (1894) from eastern India. 4 The disease is caused by Rhinosporidium seeberi, a protist belonging to the newly described class mesomycetozoea at the animal-fungus boundary. 1, 5 In 1923, Ashworth coined the term Rhinosporidium seeberi after Guillermo Seeber, who submitted a doctoral thesis in 1900. 4 Although rhinosporidiosis has been reported to occur in the Americas, Europe, Africa, and Asia, it is far more common in the tropics, and the greatest prevalence is seen in southern India and Sri Lanka. 1, 6 Rhinosporidiosis is transmitted by direct contact with the spores of R seeberi through dust, infected clothing, or fingers, and through swimming in stagnant water contaminated with the spores. Transepidermal elimination of sporangia also propagates the endospores by an active water-dependent process. In most tropical areas, rivers and lakes are the predominant media of transmission. The most prevalent site of infection is the nasal cavity. 1 The organism has developed several mechanisms of immune evasion (immune deviation, suppressor immune reactions, immunoglobulin binding, and antigenic variation), rendering both humoral and cell-mediated immunity ineffective. 5 The disease affects mostly males (70 to 90%), and the incidence is greater in those aged between 20 and 40 years. 7 Nasopharyngeal infections preferentially affect males, while ocular infection is more prevalent in females. 1 Rhinosporidiosis produces granulomatous inflammation of the affected tissues. The infection causes the development of painless intranasal papules that evolve into a large, hyperplastic, polypoidal mass that characteristically bleeds easily and has a strawberry background with white dots (representing the sporangia of the fungus). 1, 6 The polypoidal nasal mass is usually unilateral, pedunculated, and rarely exteriorizes.
Other mucosal sites involved less frequently include the palpebral conjunctiva, oropharynx, nasopharynx, maxillary antrum, larynx, external ear canal, parotid duct cyst, and genitalia. 3, 6 Oral and oropharyngeal lesions may produce mechanical obstruction, causing difficulty in breathing and/or food intake. 6 Dissemination to trachea, lung, urethra, liver, genitalia, lacrimal sac, and bone is uncommon. 1, 3, 6 Dissemination, which can be fatal, occurs more commonly in association with immunodeficient disorders (such as AIDS). It can spread via body fluids such as ascitic fluid and blood. Airway obstruction, profuse bleeding, and multiorgan failure often precipitate death. 4 Figure 2 . A: Telescopic laryngoscopy shows the reddish, strawberry-like mass with whitish spots on its surface, involving the glottis and subglottis and narrowing the glottic chink. B: Fiberoptic laryngoscopic examination reveals a large, pedunculated rhinosporidial mass occluding the tracheal lumen. Laryngotracheal rhinosporidiosis in our patient could have been due to implantation of spores into laryngeal and tracheal mucosa during episodes of recurrent bleeding from the nasopharyngeal lesions. Bronchoscopic biopsy of the tracheal lesions could be dangerous because of the risk of bleeding and aspiration. CT of the neck and thorax is preferred in these situations to evaluate the extent of laryngotracheal lesions. Virtual bronchoscopy, a novel CT-based imaging technique that allows a noninvasive intraluminal evaluation of the tracheobronchial tree, could be useful for the diagnosis of airway disease, with sensitivity of about 84% and specificity of about 75%. 3 The histopathologic diagnosis is based on the demonstration of the characteristic thick-walled giant sporangia (measuring 60 to 450 µm or more in diameter) in various stages of development and containing sporangiospores (7 to 15 µm in diameter, and up to 12,000 in number). 1,6 R seeberi can be easily identified in hematoxylin and eosin (H&E)-stained sections. Spores and sporangia are better demonstrated by periodic acid-Schiff testing, Mayer mucicarmine stain, Verhoeff-van Gieson stain, and Grocott-Gomori methamine silver stain. 8, 9 Except for one report by Levy et al, 10 cultivation has not been described as successful. However, tests for as-sessing the viability of the organism recently have been developed. A proportion of the spherical bodies that were provisionally regarded as the electron-dense bodies of the endospores can reduce the salt MTT (3-[4,5-dimethyl-2-thiazolyl]-2,5diphenyl-2H-tetrazolium bromide) to a formazan that can be visualized microscopically. MTT reduction as an indicator of viability of the endospores has been used to demonstrate the efficacy of several biocides. 5, 8 Complete surgical excision is the only reliable treatment available. Cauterization/ablation of the base following surgical excision is strongly recommended as local recurrences are common due to spillage of sporangia. 1 Rigid bronchoscopy combined with tracheostomy is useful in the removal of these laryngotracheal lesions. The likelihood of bleeding from these lesions makes surgical intervention difficult. 3 In our case, a preliminary tracheostomy was performed followed by direct laryngoscopic excision of the laryngeal lesions and rigid-bronchoscopy-guided excision of the tracheal lesions. No rhinosporidial lesions were visualized in the bilateral bronchi. The recurrence rate of nasal lesions after surgery is approximately 10%, but that of laryngotracheal lesions is unknown. 3 Dapsone is claimed to be effective as it arrests the maturation of sporangia, accelerates the degenerative changes in them, accentuates the granulomatous response with fibrosis, and prevents recurrence by interfering with the folic acid metabolism of the organism. 1, 4 Local injection of amphotericin B may be used as an adjunct treatment to surgery to prevent reinfection and spread of the disease. 6, 8 In conclusion, rhinosporidiosis is a chronic granulomatous disease that usually affects mucous membranes of the nose, nasopharynx, and ocular conjunctiva. To the best of our knowledge, ours is one of the rarest reports of rhinosporidiosis, involving the larynx and trachea. Laryngotracheal involvement poses many diagnostic and therapeutic challenges because of the potential for bleeding and aspiration. Our case may suggest a relationship between nasopharyngeal and laryngotracheal lesions in the 
